|
Market Closed -
Euronext Paris
11:55:00 2026-08-13 am EDT
|
5-day change | 1st Jan Change | ||
| 157.50 EUR | +1.29% |
|
-1.38% | +32.35% |
| Aug. 04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| Aug. 03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 14.72B | |||||
| 1,088B | |||||
| 629B | - | - | - | ||
| 440B | |||||
| 359B | |||||
| 291B |
- Stock Market
- Stocks
- IPN Stock
- Charts Ipsen
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
